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Abstract
Background and Purpose
It has been suggested that CT Perfusion acquisition times<60 seconds are too short to
capture the complete in and out-wash of contrast in the tissue, resulting in incomplete time
attenuation curves. Yet, these short acquisitions times are not uncommon in clinical prac-
tice. The purpose of this study was to investigate the occurrence of time attenuation curve
truncation in 48 seconds CT Perfusion acquisition and to quantify its effect on ischemic core
and penumbra estimation in patients with acute ischemic stroke due to a proximal intracrani-
al arterial occlusion of the anterior circulation.
Materials and Methods
We analyzed CT Perfusion data with 48 seconds and extended acquisition times, assuring
full time attenuation curves, of 36 patients. Time attenuation curves were classified as com-
plete or truncated. Ischemic core and penumbra volumes resulting from both data sets were
compared by median paired differences and interquartile ranges. Controlled experiments
were performed using a digital CT Perfusion phantom to investigate the effect of time atten-
uation curve truncation on ischemic core and penumbra estimation.
Results
In 48 seconds acquisition data, truncation was observed in 24 (67%) cases for the time at-
tenuation curves in the ischemic core, in 2 cases for the arterial input function and in 5
cases for the venous output function. Analysis of extended data resulted in smaller ischemic
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cores and larger penumbras with a median difference of 13.2 (IQR: 4.3–26.0)ml (P<0.001)
and; 12.4 (IQR: 4.1–25.7)ml (P<0.001), respectively. The phantom data showed increasing
ischemic core overestimation with increasing tissue time attenuation curve truncation.
Conclusions
Truncation is common in patients with large vessel occlusion and results in repartitioning of
the area of hypoperfusion into larger ischemic core and smaller penumbra estimations.
Phantom experiments confirmed that truncation results in overestimation of the
ischemic core.
Introduction
Multiple randomized controlled trials have shown the efficacy of intravenous thrombolysis up
to 4.5 hours from onset in patients with acute ischemic stroke [1]. Although convincing evi-
dence is currently lacking, based on experience, patients who do not respond to intravenous
thrombolysis or are not eligible for intravenous thrombolysis, may receive intra-arterial treat-
ment (IAT) up to 6 to 8 hours from onset [1]. It has been demonstrated that pre-treatment is-
chemic core volume is an important predictor of outcome after intra-arterial treatment [2][3].
Although diffusion weighted imaging is the best imaging modality for this purpose [4] its use is
currently limited by its unavailability in the acute setting. It has been proposed that CT Perfu-
sion (CTP) parameters like cerebral blood flow (CBF), cerebral blood volume (CBV), mean
transit time (MTT) and time to peak (TTP) may potentially be used to estimate areas of irre-
versible brain damage (ischemic core) and potential salvageable areas of hypoperfusion (ische-
mic penumbra) [5][6]. Due to its speed, few contraindications for its use [7], and wide
availability of CT scanners in emergency departments, CTP has the potential to provide clinical
decision support in patients with acute ischemic stroke [8][9]. However, before its acceptance
in clinical practice, there are several CTP pitfalls, which compromise accurate CTP analysis
that need to be dealt with. Examples of known pitfalls are patient movement [10], errors in
placement of arterial input function (AIF) and venous output function (VOF), heterogeneity in
thresholds and post-processing [11][12]. A limited acquisition time of<60 seconds is another
potential source of error because delayed arrival of contrast agent may result in incomplete
capture of the tissue time attenuation curves (TACs) during acquisition [13][14][15]. It is
known that truncation of tissue TACs may preclude accurate calculation of CTP parameters
[12][16][17]. Despite recommendations of using an acquisition time up to 90 seconds [18],
many hospitals still use a potential too short acquisition time of<60 seconds[19][20][21]. Fur-
thermore, the effect of truncation of tissue TACs on ischemic core and penumbra volume esti-
mation is unknown at present.
The aim of this observational case cohort study is to determine the occurrence of tissue
TAC truncation in 48 seconds acquisition data. Furthermore, we investigate the effect of trun-
cation using a digital CTP phantom and by comparison of CTP analysis on standard and ex-
tended acquisition image data of patients with acute ischemic stroke due to a proximal
intracranial arterial occlusion of the anterior circulation.
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Materials and Methods
Digital head phantom data
We have used a previously validated digital CTP head phantom [22] to generate a “gold stan-
dard” and quantify the effect of tissue TAC truncation on ischemic core and penumbra estima-
tion. Forty-eight seconds CTP data with truncated tissue TACs was created by simulating
delayed arrival of contrast agent in the hypoperfused tissue (ischemic core and penumbra). We
created the CTP phantom with similar settings as the CTP imaging protocol of hospital A
(Table 1). A very small ischemic core (0.1 ml) and large penumbra volume (61 ml) was created
at the right hemisphere by applying a mask to the phantom CTP data that designated lower
perfusion values for the calculation of the TACs. Eight phantom data sets were constructed,
with delay in the arrival of the contrast agent in the hypoperfused tissue ranging from 0 to 13
seconds to simulate different proportions of the TAC being truncated. Arrival delay of contrast
agent was simulated by shifting the TACs of the hypoperfused tissue in time relative to the
TACs of the healthy tissue (see Fig. 1). The generated image data was suitable for further
CTP analysis.
Patient selection
In our university medical centers, patients with acute ischemic stroke are screened by NCCT.
Patients that do not respond to intravenous thrombolysis or are not eligible for intravenous
thrombolysis are screened for inclusion in the MRCLEAN trial [23] by CTA and optional CTP.
All patients included in the MRCLEAN trial in our university medical centers that underwent
CTP with a total acquisition time of 210 seconds were retrospectively included in this study.
Patients with a proximal intracranial arterial occlusion of the anterior circulation on CTA are
Table 1. Scanner and settings.
Hospital A Hospital B
Number of patients
scanned
28 (patients 1 to 28) 8 (patients 29 to 36)
Scanner 64-slice scanner (sliding gantry Sensation 64, Siemens Medical
Solutions, Forchheim, Germany)
128-slice scanner (Philips Brilliance iCT; Best, the
Netherlands).
Total acquisition time 210 s 210 s
Standard Acquisition 1 image every 2 s for the ﬁrst 48 s 1 image every 2 s for the ﬁrst 48 s
Extended acquisition 60 s after start 1 image every 30 s 60 s after start 1 image every 30 s
Image acquisition
parameters
80 kVp, 100 mAs 80 kVp, 100 mAs
Collimation 24 x1.2 mm 128 x 0.625 mm
Brain coverage 28.8 mm 40 mm to 80 mm
FOV 300 mm 220 mm
Reconstructed section
width
4.8 mm 5.0 mm
Slice location At the level of the third ventricle At the level of the third ventricle
Contrast material Iopromide (Ultravist 300; Bayer HealthCare Pharmaceuticals,
Pine Brook, New Jersey)
Iopromide (Ultravist 300; Bayer HealthCare
Pharmaceuticals, Pine Brook, New Jersey)
Contrast volume 40 ml followed by 40 ml of saline 40 ml followed by 40 ml of saline
Injection rate 4 ml/s via 18 G cannula in the right antecubital vein 6 ml/s via 18 G cannula in the right antecubital vein
Start of acquisition 7 seconds after the start of injection of contrast agent simultaneously with the start of injection of contrast agent
doi:10.1371/journal.pone.0119409.t001
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eligible for inclusion in the MRCLEAN. Patients with cerebral ischemia within the previous 6
weeks, and severe head injury in the previous four weeks were excluded.
Ethics statement
The CTP protocol has been approved by the institutional review board (Medisch Ethische
Toetsings Commissie) from the Academic Medical Center, Amsterdam, The Netherlands. Pa-
tients or legal representatives signed informed consent.
CTP imaging protocol
The protocol, as introduced by the Dutch Acute Stroke Trial [24], comprises one image every 2
seconds for the first 48 seconds, followed at 60 seconds after start with a second acquisition of
one image every 30 seconds. Resulting in a combined acquisition time of 210 seconds. Details
of the protocol can be found in Table 1. The effective dose of the standard CTP acquisition was
0.43 mSv and the total effective dose of the extended acquisition was 0.53 mSv.
CTP analysis
The CTP analysis was performed by a trained observer (with two years of experience) using
Philips software (Philips Extended Brilliance Workspace, version 3.5, Brain CT Perfusion
Package, Philips Healthcare, Best, The Netherlands). The default preprocessing steps included
filtering, registration and segmentation of brain tissue.
To select the location for the AIF, two regions of interest were selected, containing the ante-
rior cerebral artery or middle cerebral artery (MCA) in the hemisphere contralateral to the oc-
clusion. In each region of interest the voxel with the highest attenuation was automatically
selected. Out of these options, the position with the highest attenuation was selected for the
AIF [25]. For the VOF, two regions of interest were selected containing either the superior sag-
ittal sinus or straight sinus. Similar to the AIF selection, the position with the highest attenua-
tion was selected for the VOF [26]. The analysis resulted in maps of the CBF, MTT, CBV, and
TTP. Calculation of these parameters and determination of the thresholds for ischemic core
Fig 1. Tissue TACs of the hypoperfused and healthy tissue in the phantom data. In green is the TAC of the healthy tissue. In red is the TAC of the
hypoperfused tissue without arrival delay of contrast agent (the original phantom data). The blue curves are the shifted TACs of the hypoperfused tissue of
each individual phantom (n = 7). Each curve has a different amount of time shift (from left to right:1, 3, 5, 7, 9, 11 and 13 seconds), and thus arrival delay of
contrast agent, relative to the TAC of the healthy tissue (green). With increasing time shift the proportion of the TAC that is truncated increases.
doi:10.1371/journal.pone.0119409.g001
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and penumbra are previously reported [27]. Ischemic penumbra was defined as a relative MTT
50% higher than that of the contralateral hemisphere [28]. Ischemic core was defined as a rela-
tive MTT> 1.5 and a CBV lower than 2.0 ml/100g [27].
CTP analysis was performed on the 48 seconds patient and phantom data. After merging
the standard and extended imaging data, the combined 210 seconds patient data was analyzed.
To minimize intraobserver variability the AIF and VOF, were chosen in the same vessel and lo-
cation for the 48 and 210 seconds patient data. Regions of interest were placed in the ischemic
core, as defined by the software, to inspect tissue TACs. The TACs for the 48 seconds and 210
seconds image data were classified as complete or truncated in consensus (with 2 years and
with more than 10 years of experience). Truncation was defined as an incomplete capture of
the TAC either due to incomplete wash-in or wash-out of the first-pass bolus of contrast agent
during the acquisition (see Figs. 2–4). Volumes of the ischemic core and penumbra were re-
corded. For a subset of 18 patients the 48 seconds data was measured a second time. The ob-
server selected the same vessel location for the AIF and VOF as for the first measurement. We
also determined whether patients had mismatch, which has been suggested as a selection crite-
ria for therapy [29][30]. Mismatch was defined as an ischemic core< 70 ml and a penumbra of
at least 10 ml and 80% larger than the ischemic core [29].
Statistical analysis
The median and interquartile ranges (IQRs) of paired absolute and relative differences in vol-
ume of ischemic core, penumbra, and perfusion abnormality (ischemic core + penumbra) be-
tween the data from the standard and extended acquisition time were determined. Median
relative difference of the measured volumes was calculated as the paired difference in volume
divided by the average volume. The Wilcoxon signed-rank test was used to compare statistical
significance of the median differences. P values smaller than 0.05 were considered statistically
significant. Intra-observer variability was determined by Bland Altman 95% limits of agree-
ment and calculation of the Intraclass Correlation Coefficient. Statistical analyses were per-
formed using IBM SPSS version 20 (IBM Corp., Armonk, NY, USA).
Results
Digital head phantom data
A CTP summary map resulting from CTP analysis of the original phantom data, without arriv-
al delay of contrast agent and thus without truncation, is shown in Fig. 5. The volumes of ische-
mic core and penumbra of the 8 digital phantom data sets, with each a different proportion of
the tissue TAC being truncated are shown in Fig. 6. With increasing time shift of the TACs of
the hypoperfused tissue the proportion of the TAC that is truncated increases. Fig. 6 shows
that for a delay of 3 seconds and more the ischemic core volume increases, and the penumbra
volume decreases with increasing delay. Note tissue TAC truncation for a delay of 3 seconds
and more in Fig. 1.
Patient selection
Fifty-eight patients with acute ischemic stroke due to a proximal intracranial arterial occlusion
of the anterior circulation underwent CTP analysis with an acquisition time of 210 seconds.
Thirteen patients were excluded because of severe head movement during the standard and ex-
tended acquisition and five patients were excluded because of movement during the extended
acquisition. Four patients were excluded because of impossibility of combining the regular
CTP scans with the extended scans in the software due to differences in pixel spacing (N = 2),
Effect of CTP Acquisition Time on Ischemic Core Estimation
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and insufficient contrast supply (N = 2). The exclusion resulted in 36 patients (mean age: 61
years, age range: 34–86 years, median National Institutes of Health Stroke Scale (NIHSS) 16
(IQR: 12–21)) suitable for analysis. See Table 2 for the patient demographics, clinical character-
istics, Alberta Stroke Program Early CT score (ASPECTS), and the measured perfusion
defect volumes.
Patient CTP data
In the standard 48 seconds image data, truncation of the VOF curve with truncation of the AIF
curve was found in 2 (6%) patients, truncation of the VOF curve without truncation of the AIF
was found in 5 (14%) patients. For all patients with AIF and/or VOF truncation, tissue TAC
Fig 2. Examples of tissue time attenuation curve truncation with normal AIF and VOF.Normal AIF and VOF for the CTP data of patient 19 (left) and
corresponding truncated tissue TAC for the 48 seconds acquisition data of the same patient (right). These figures illustrates that an acquisition time of 48
seconds can be insufficient to capture the complete outwash of contrast agent from the ischemic tissue.
doi:10.1371/journal.pone.0119409.g002
Fig 3. Examples of AIF and VOF truncation. Example of normal AIF curve with truncated VOF curve (left).Example of truncated AIF and VOF curves
(right). For both examples longer acquisition time is needed to capture the complete in-wash and outwash of contrast agent.
doi:10.1371/journal.pone.0119409.g003
Effect of CTP Acquisition Time on Ischemic Core Estimation
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Fig 4. Examples of complete and incomplete tissue time attenuation curves.Complete tissue time attenuation curves from patient 6 (upper left) and
patient 24 (upper right). Truncated tissue time attenuation curve from patient 7 (bottom left) and 3 (bottom right). The AIF and VOF of patients 7 and 3
were complete.
doi:10.1371/journal.pone.0119409.g004
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truncation was also observed. Furthermore truncation of tissue TAC, without truncation of the
AIF or VOF, was found in 24 (67%) patients. There was no truncation of TACs in the 210 sec-
onds image data.
For 35 out of 36 patients, the ischemic core was smaller for extended CTP acquisition time
image data. Fig. 7 shows a typical CTP summary map with its corresponding tissue TACs in
Fig. 2. Only for patient 20, the ischemic core was slightly larger with the longer acquisition
time.
See Table 3 for the differences in volumes between the extended and standard acquisition
time. The ischemic core was smaller, the penumbra larger, and there was no significant differ-
ence in total perfusion abnormality for the extended acquisition with a median paired differ-
ence of 13.2 (IQR 4.3–26.0) ml (P<0.001), 12.4 (IQR 4.1–25.7) ml (P<0.001), and 0.2 (IQR-
1.6–2.7) ml (P = 0.43), respectively. The median relative difference in volume of ischemic core,
ischemic penumbra, and total perfusion abnormality was 84.3 (IQR 31.8–136) % (P<0.001),
32.8 (IQR 14.1–69.6) % (P<0.001), 0.7 (IQR-4.0–4.0) % (P = 0.5), respectively.
For patients without any truncation, the ischemic core was smaller for the extended acquisi-
tion with a median paired difference of 2.0 (IQR 0.7–5.6) ml (P = 0.14) and a median relative
difference of 28.2 (IQR 9.5–92.3) % (P = 0.23). For patients with only truncation of the tissue
TAC, the ischemic core was smaller for the extended acquisition with a median paired
Fig 5. Summary Maps from original phantom data. CTP summary map for all slice locations resulting from analysis of the original CTP phantom data
without arrival delay of contrast agent.
doi:10.1371/journal.pone.0119409.g005
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difference of 14.4 (IQR 6.1–20.9) ml (P<0.001) and a median relative difference of 84.3 (IQR
43.1–139) % (P<0.001). For the data with 28 mm brain coverage (hospital A) the ischemic
core was smaller for the extended acquisition with a median paired difference of 11.9 (IQR
3.6–22.6) ml (P<0.001) and a median relative difference of 89.4 (IQR 31.2–164) % (P<0.001).
For the data with 40 to 80 mm brain coverage (hospital B) the ischemic core was smaller for
the extended acquisition with a median paired difference of 16.1 (IQR 6.0–47.9) ml (P = 0.012)
and a median relative difference of, 57.3 (IQR 31.8–101) % (P = 0.012).
The median paired difference between the two repeated measurements was 0.2 (IQR-0.4–
2.7) ml for the ischemic core and 0.1 (IQR 0.0–1.5) ml for the penumbra. The Intraclass corre-
lation coefficient was 0.99 for the ischemic core and 0.96 for the penumbra. The Bland Altman
95% limits of agreement between the repeated measurements ranged from −3.8ml–4.9ml for
the ischemic core and −3.8ml–4.6ml for the penumbra.
Mismatch was detected for 25 (70%) patients in the extended data series compared to 14
(39%) patients for the standard acquisition time.
Fig 6. Ischemic core and penumbra from phantom data. This figure shows the effect of shifting TACs of the hypoperfused tissue relative to the TACs of
the healthy tissue, and thus simulating contrast arrival delay, on ischemic core and penumbra determination.
doi:10.1371/journal.pone.0119409.g006
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Discussion
This study shows that truncation of TACs is common in patients with acute ischemic stroke
due to a proximal intracranial arterial occlusion of the anterior circulation. Tissue TAC trunca-
tion caused overestimation of ischemic core and underestimation of ischemic penumbra in
phantom experiments. A similar effect is observed in patient data in which extended acquisi-
tion time results in complete TACs and repartitioning of the area of hypoperfusion into smaller
ischemic core volumes and larger penumbra volumes compared with standard acquisition
time.
If mismatch analysis had been used for patient selection, almost one-third of the patients
would have been selected based on extended CTP acquisition but rejected for therapy when
standard acquisition time was used.
The prevalence of AIF truncation found in our study is similar to the 9% (1/11) reported
previously [31]. Prevalence of tissue TAC truncation in our study is much higher than the pre-
viously reported of 31% (4/13) in patients with symptoms of MCA occlusion [32], and 9%
(1/11) in patients with a proximal occlusion of the anterior circulation [31]. Schaefer et al. [31]
used a longer default acquisition time (60 seconds), and a higher injection rate of the contrast
agent (7ml/s), which may explain the lower prevalence [33].
CBV is calculated by dividing the area under the tissue TAC by the area under the AIF [27]
[34]. Truncated TACs have a smaller area under the curve than complete TACs and therefore
causes underestimation of CBV and larger ischemic cores. For some patients without trunca-
tion, the ischemic core was slightly smaller using longer acquisition times. This may be caused
by the software selecting a larger area under the TAC as first pass bolus for the extended acqui-
sition time resulting in larger CBV and smaller ischemic core. However, we believe that the
possibility of a larger CBV estimation, found in patients without truncation, due to longer
Fig 7. CTP summary maps from patient 19. CTP summary map for the 48 seconds acquisition data with truncated tissue TAC (left). Corresponding CTP
summary map for the 210 seconds acquisition data with complete TACs (right). Red: ischemic core, green: ischemic penumbra (See Fig. 2 for corresponding
TAC curves).
doi:10.1371/journal.pone.0119409.g007
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acquisition times cannot explain the large differences in ischemic core size that we have found
in patients with truncated TAC. Since the intra-observer variability is small we are convinced
that the observer-dependency is minor compared to the differences between standard and ex-
tended CTP acquisitions.
The results from this study pertain to the use of Philips software and used parameters to de-
fine ischemic core and penumbra. Since CTP analysis methods vary per software vendor [35]
we expect that the effect of truncation varies for different software packages and use of different
parameters. Truncation of the VOF seems to have little effect on the ischemic core estimation
when relative CBF is used as a threshold to define the ischemic core [17].
It would be interesting to investigate what the effect of truncation is when different parame-
ters (e.g. relative CBF or relative CBV) or other software packages are used to define ischemic
core and penumbra.
Due to the occlusion causing the ischemic stroke the arrival of contrast agent is delayed and
the mean transit time is prolonged in hypoperfused tissue [26], therefore an acquisition time of
*50 s can be potentially be too short to capture the complete TAC. Delayed arrival of contrast
agent in the tissue causes a shift of the TAC towards the end of the acquisition, and may cause
TAC truncation. Besides the occlusion causing the stroke arrival delay of contrast agent may
have various extracranial causes, for example, low cardiac output, aortic dissection, severe
proximal ICA stenosis, and ICA dissection [36][37][38]. Intracranial occlusions can also cause
sluggish flow in the ICA and may cause delayed contrast arrival through collaterals [36][37].
Due to an intracranial occlusion, the contrast agent may arrive via the collateral pathway and is
delayed compared with regular perfusion [39]. A large occluded proximal intracranial artery
may cause more contrast arrival delay compared with a distal occlusion [40]. Therefore, the
prevalence of truncation in this study may be higher than in the general stroke population.
This study has a number of limitations. The software uses MTT to define ischemic penum-
bra, which may result in overestimation of penumbra for patients with an extracranial ICA ste-
nosis [12][41]. The low temporal resolution of the additional acquisition may result in less
accurate results [42]. However, because of the dose restrictions it is not ethical to scan such a
long time with a high temporal resolution. We used a delay sensitive CTP analysis method,
which may contribute to an overestimation of the ischemic core [31]. It is quite possible that
the use of delay insensitive method could reduce the difference in ischemic core sizes between
Table 3. Difference in volumes between the extended (210 s) and standard (48 s) acquisition time (extended-standard).
Absolute median paired difference Relative median paired difference
ischemic core
(IQR) [ml]
ischemic
penumbra
(IQR) [ml]
total perfusion
abnormality
(IQR) [ml]
ischemic core
(IQR) [%]
ischemic
penumbra
(IQR) [%]
total perfusion
abnormality
(IQR) [%]
All patients (n = 36) -13.2 (-26.0 –-4.3) 12.4 (4.1–25.7) 0.24 (-1.6–2.7) -84.3 (-136 –-31.8) 32.8 (14.1–
69.6)
-.7 (-4.0–4.0)
Patients without truncation (n = 5) -2.0 (-5.6–0.7) 3.6 (1.3–13.4) -2.7 (-0.2–8.8) -28.2 (-92.3–9.5) 9.5 (2.3–39.1) 3.7 (-52.0–21.3)
Patients with only tissue TAC
truncation (n = 24)
-14.4 (-20.9 –-6.1) 13.9 (6.0–19.7) -0.5 (-1.6–1.8) -84.3 (-139 –-43.1) 28.4 (14.1–
52.3)
-1.2 (-3.9–1.2)
Patients with VOF or VOF and AIF
truncation (n = 7)
-30.9 (-41.5 –-12.0) 28.8 (10.7–50.3) 1.7 (-2.9–5.3) -121 (-183 –-61.8) 117 (65.1–
122)
2.5 (-53.0–8.8)
Hopsital A (28. mm coverage)
(n = 28)
-11.9 (-22.6 –-3.6) 12.4 (3.7–22.1) 0.4 (-1.4–3.1) -89.4 (-164 –-31.2) 44.6 (16.9–
72.6)
1.0 (-15.0–4.2)
Hospital B (40 mm to 80 mm
coverage (n = 8)
-16.1 (-47.9 –-6.0) 13.7 (7.1–46.7) -0.0 (-5.0–1.7) -57.3 (-101 –-31.8) 22.5 (6.5–
37.5)
0.2 (-3.9–1.2)
* truncation as assessed on the 48 seconds image data.
doi:10.1371/journal.pone.0119409.t003
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the standard and extended acquisition times. An ischemic core measurement “gold standard”
like diffusion weighted imaging for comparison with the CTP summary maps was not avail-
able. Follow-up non-contrast-enhanced CT scans performed 3–5 days after the CTP were
available, but reliable comparison was hampered due to ischemic core growth [43][44]. There-
fore we were not able to validate the use of current available thresholds for the extended acqui-
sition with clinical data. The phantom data was used to generate a “gold standard” and enabled
us to quantify the effect of tissue TAC truncation on ischemic core and penumbra estimation.
Whether the ischemic core volumes of the 48 or 210 seconds data are more accurate, versus a
reference standard, will depend on whether there was truncation, and the proportion of the
TAC being truncated in the data used to derive the 2.0g/100mL CBV threshold for ischemic
core. However truncation causes incorrect CTP analysis and may causes severe ischemic core
overestimation. We have used the same thresholds for data from the standard as extended ac-
quisition. These thresholds might not be optimal for data from the extended acquisition and
should be validated.
Differences in scan protocols may have resulted in variation in prevalence of truncation, but
it is important to note that both scan protocols, with different injection protocols, can result in
truncation. For hospital B, which uses a higher injection rate than hospital A, there was no
truncation of the AIF or VOF observed. Since the absolute difference in ischemic core between
the extended and standard acquisition time was larger for full brain coverage, the small brain
coverage of 28.8 mm, may have caused underestimation of the volume differences. A relative
small sample size was analyzed and many patients were excluded because of movement. Pa-
tients with acute ischemic stroke may be agitated and tend to move which limits the feasibility
of CTP [45].
Although strong evidence that patients benefit from IAT after 6 to 8 hours from onset is
currently lacking [1], it has been suggested that patients with a large ischemic core (>100 ml)
are anyway unlikely to benefit from IAT [46]. Overestimation of ischemic core affects mis-
match analysis and may result in incorrectly withholding the patient from treatment. Therefore
accurate determination of the ischemic core and penumbra is crucial for CTP to become a stan-
dard treatment decision tool in clinical practice. The potential harm of incorrectly withholding
a patient from treatment justifies the slightly larger effective dose of the longer acquisition.
TAC truncation is common in 48 seconds imaging data and as shown in phantom data results
in overestimation of the ischemic core. Longer CTP acquisition time prevents TAC truncation
and may improve the accuracy of ischemic core estimation.
Conclusions
In this study we observed that in 48 second acquisition data, truncation of TACs is common in
patients with acute ischemic stroke due to a proximal intracranial arterial occlusion of the ante-
rior circulation. Phantom experiments confirmed that truncation results in overestimation of
the ischemic core. By using sufficiently long acquisition times, time attenuation curve trunca-
tion can be prevented which results in smaller ischemic core estimations and may affect
treatment decisions.
Acknowledgments
The MR CLEAN investigators:
Local principal investigators: Diederik W. Dippel, Patrick A. Brouwer, Erasmus MC Rotter-
dam; Yvo B. Roos, Charles B. Majoie, Academisch Medisch Centrum Amsterdam; Robert J.
van Oostenbrugge, Wim H. van Zwam, Maastricht UMC. Jelis Boiten, Geert J. Lycklama à
Nijeholt, MC Haaglanden Den Haag; Marieke J. Wermer, Marianne A. van Walderveen, Leids
Effect of CTP Acquisition Time on Ischemic Core Estimation
PLOS ONE | DOI:10.1371/journal.pone.0119409 March 19, 2015 14 / 18
Universitair Medisch Centrum Leiden; L. Jaap Kappelle, Rob T. Lo, UMC Utrecht; Ewoud J.
van Dijk, Joost de Vries, UMC St. Radboud Nijmegen; Wouter J. Schonewille, Jan Albert Vos,
St. Antonius Ziekenhuis Nieuwegein; Jeannette Hofmeijer, Jacques A. van Oostayen, Rijnstate
Ziekenhuis Arnhem; Patrick C. Vroomen, Omid Eshghi, UMC Groningen; Paul L. de Kort,
Willem Jan van Rooij, St. Elisabeth Ziekenhuis Tilburg; Koos Keizer, Xander Tielbeek, Cathar-
ina Ziekenhuis Eindhoven; Bas F. de Bruijn, Lukas C. van Dijk, Haga Ziekenhuis Den Haag; J.
S. Peter van den Bergh, Boudewijn A. van Hasselt, Isala Klinieken, Zwolle; Leo A. Aerden,
René J Dallinga, Reinier de Graaf Gasthuis, Delft; Tobien Schreuder, Roel J Heijboer, Atrium
MC Heerlen;
Heleen M. den Hertog, Dick G. Gerrits, Medisch Spectrum Twente Enschede; Marieke C.
Visser, Joost C. Bot, VUMC Amsterdam.
Executive committee: Diederik W.J. Dippel, Erasmus MC Rotterdam; Aad van der Lugt,
Erasmus MC Rotterdam;
Charles B. Majoie, AMC Amsterdam; Yvo B.W.E.M. Roos, AMC Amsterdam; Robert J. van
Oostenbrugge, Maastricht UMC; Wim H. van Zwam, Maastricht UMC.
Imaging assessment committee: Charles B. Majoie, chair; Wim H. van Zwam; Geert J. Lyck-
lama à Nijeholt; Marianne A. van Walderveen, Joost C. Bot; Henk A. Marquering; Ludo F. Bee-
nen; Marieke E. Sprengers; Sjoerd Jenniskens, René van den Berg; Aad van der Lugt.
Independent DSA reader: Albert J. Yoo, Massachussets General Hospital, Boston, USA.
Outcome assessment committee: Yvo B. Roos, chair; Peter J. Koudstaal; Jelis Boiten; Ewoud
J. van Dijk.
Adverse event committee: Robert J. van Oostenbrugge, chair; Marieke J. Wermer; H. Zwen-
neke Flach
PhD-students and study coordinators: Puck S.S. Fransen, Erasmus MC Rotterdam; Debbie
Beumer, UMCMaastricht; Olvert A. Berkhemer, AMC Amsterdam, Lucie van den Berg, AMC
Amsterdam.
Trial statisticians: Ewout W. Steyerberg, Dept of Public Health, Center for Clinical Deci-
sion Sciences, Erasmus MC Rotterdam.
Hester F. Lingsma, junior researcher at the center for Clinical Decision Sciences Erasmus
MC Rotterdam.
Data Monitoring Committee: Martin M Brown (Chair), professor of stroke medicine, Insti-
tute of Neurology, University College London, UK.
Thomas Liebig, professor of neuroradiology, department of Radiology, Uniklinik Köln,
Germany;
Theo Stijnen, professor of medical statistics, department of Medical Statistics and Bioinfor-
matics at Leiden University Medical Center, The Netherlands.
Trial managers: Esther S. van der Heijden; Erasmus MC Rotterdam
Nadine M. Fleitour, AMC Amsterdam
Author Contributions
Conceived and designed the experiments: JB HAM LFMB AJR CBLMM. Performed the experi-
ments: JB AJR. Analyzed the data: JB HAM LFMB JWD AJR CBLMM. Contributed reagents/
materials/analysis tools: JB LFMB OAB AJR. Wrote the paper: JB HAM LFMB OAB JWD AJR
CBLMM.
References
1. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJB, Demaerschalk BM, et al. Guidelines for the
early management of patients with acute ischemic stroke: a guideline for healthcare professionals from
Effect of CTP Acquisition Time on Ischemic Core Estimation
PLOS ONE | DOI:10.1371/journal.pone.0119409 March 19, 2015 15 / 18
the American Heart Association/American Stroke Association. Stroke. 2013; 44: 870–947. doi: 10.
1161/STR.0b013e318284056a PMID: 23370205
2. Sanák D, Nosál’ V, Horák D, Bártková A, Zelenák K, Herzig R, et al. Impact of diffusion-weighted MRI-
measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle ce-
rebral artery occlusion treated by thrombolysis. Neuroradiology. 2006; 48: 632–9. doi: 10.1007/s00234-
006-0105-0 PMID: 16941183
3. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, González RG. MRI-based selection for
intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in select-
ing patients with acute stroke who will benefit from early recanalization. Stroke. 2009; 40: 2046–54. doi:
10.1161/STROKEAHA.108.541656 PMID: 19359641
4. Schellinger PD, Bryan RN, Caplan LR, Detre JA, Edelman RR, Jaigobin C, et al. Evidence-based
guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of
the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology. 2010; 75: 177–85. doi: 10.1212/WNL.0b013e3181e7c9dd PMID: 20625171
5. Murphy BD, Fox AJ, Lee DH, Sahlas DJ, Black SE, Hogan MJ, et al. Identification of penumbra and in-
farct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood vol-
ume measurements. Stroke. 2006; 37: 1771–7. doi: 10.1161/01.STR.0000227243.96808.53 PMID:
16763182
6. Wintermark M, Albers GW, Broderick JP, Demchuk AM, Fiebach JB, Fiehler J, et al. Acute Stroke Imag-
ing Research Roadmap II. Stroke. 2013; 44: 2628–2639. doi: 10.1161/STROKEAHA.113.002015
PMID: 23860298
7. Smith WS, Roberts HC, Chuang NA, Ong KC, Lee TJ, Johnston SC, et al. Safety and feasibility of a CT
protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive
patients. AJNR Am J Neuroradiol. 2003; 24: 688–90. PMID: 12695204
8. Donnan GA, Baron J-C, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke ther-
apy. Lancet Neurol. 2009; 8: 261–9. doi: 10.1016/S1474-4422(09)70041–9 PMID: 19233036
9. Saake M, Breuer L, Gölitz P, Köhrmann M, Schwab S, Dörfler A, et al. Clinical/perfusion CT CBVmis-
match as prognostic factor in intraarterial thrombectomy in acute anterior circulation stroke. Clin Neurol
Neurosurg. 2014; 121: 39–45. doi: 10.1016/j.clineuro.2014.03.007 PMID: 24793473
10. Fahmi F, Riordan A, Beenen LFM, Streekstra GJ, Janssen NY, de Jong HW, et al. The effect of head
movement on CT perfusion summary maps: simulations with CT hybrid phantom data. Med Biol Eng
Comput. 2013; doi: 10.1007/s11517-013-1125-7
11. Mui K, Yoo a J, Verduzco L, CopenW a, Hirsch J a, González RG, et al. Cerebral blood flow thresholds
for tissue infarction in patients with acute ischemic stroke treated with intra-arterial revascularization
therapy depend on timing of reperfusion. AJNR Am J Neuroradiol. 2011; 32: 846–51. doi: 10.3174/ajnr.
A2415 PMID: 21474633
12. Mangla R, Ekhom S, Jahromi BS, Almast J, Mangla M, Westesson P-L. CT perfusion in acute stroke:
Know the mimics, potential pitfalls, artifacts, and technical errors. Emerg Radiol. 2013; doi: 10.1007/
s10140-013-1125-9
13. Konstas AA, Lev MH. CT perfusion imaging of acute stroke: the need for arrival time, delay insensitive,
and standardized postprocessing algorithms? Radiology. 2010; 254: 22–5. doi: 10.1148/radiol.
09091610 PMID: 20032139
14. Lev MH. Perfusion imaging of acute stroke: its role in current and future clinical practice. Radiology.
2013; 266: 22–7. doi: 10.1148/radiol.12121355 PMID: 23264524
15. Kamalian S, Kamalian S, Konstas AA, Maas MB, Payabvash S, Pomerantz SR, et al. CT perfusion
mean transit time maps optimally distinguish benign oligemia from true “at-risk” ischemic penumbra,
but thresholds vary by postprocessing technique. AJNR Am J Neuroradiol. 2012; 33: 545–9. doi: 10.
3174/ajnr.A2809 PMID: 22194372
16. Deipolyi AR, Wu O, Macklin EA, Schaefer PW, Schwamm LH, Gilberto Gonzalez R, et al. Reliability of
cerebral blood volumemaps as a substitute for diffusion-weighted imaging in acute ischemic stroke. J
Magn Reson Imaging. 2012; 36: 1083–7. doi: 10.1002/jmri.23740 PMID: 22761110
17. Campbell BCV, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, et al. Cerebral blood
flow is the optimal CT perfusion parameter for assessing infarct core. Stroke. 2011; 42: 3435–40. doi:
10.1161/STROKEAHA.111.618355 PMID: 21980202
18. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron J-C, et al. Acute stroke imaging
research roadmap. Stroke. 2008; 39: 1621–8. doi: 10.1161/STROKEAHA.107.512319 PMID:
18403743
19. Lin L, Bivard A, Levi CR, Parsons MW. Comparison of Computed Tomographic and Magnetic Reso-
nance Perfusion Measurements in Acute Ischemic Stroke: Back-to-Back Quantitative Analysis. Stroke.
2014; 1727–1732. doi: 10.1161/STROKEAHA.114.005419
Effect of CTP Acquisition Time on Ischemic Core Estimation
PLOS ONE | DOI:10.1371/journal.pone.0119409 March 19, 2015 16 / 18
20. Turk AS, Magarick JA, Frei D, Fargen KM, Chaudry I, Holmstedt CA, et al. CT perfusion-guided patient
selection for endovascular recanalization in acute ischemic stroke: a multicenter study. J Neurointerv
Surg. 2013; 5: 523–7. doi: 10.1136/neurintsurg-2012-010491 PMID: 23182902
21. Cortijo E, García-Bermejo P, Calleja AI, Pérez-Fernández S, Gómez R, Del Monte JM, et al. Intrave-
nous thrombolysis in ischemic stroke with unknown onset using CT perfusion. Acta Neurol Scand.
2013; 1–6. doi: 10.1111/ane.12160
22. Riordan AJ, Prokop M, Viergever MA, Dankbaar JW, Smit EJ, de Jong HWAM. Validation of CT brain
perfusion methods using a realistic dynamic head phantom. Med Phys. 2011; 38: 3212. doi: 10.1118/1.
3592639 PMID: 21815396
23. Fransen PSS, Beumer D, Berkhemer OA, Berg LA Van Den, Lingsma H. MR CLEAN, a multicenter ran-
domized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study pro-
tocol for a randomized controlled trial MR CLEAN, a multicenter randomized clinical trial of
endovascular treatment for a. 2014;
24. Van Seeters T, Biessels GJ, van der Schaaf IC, Dankbaar JW, Horsch AD, Luitse MJ, et al. Prediction
of outcome in patients with suspected acute ischaemic stroke with CT perfusion and CT angiography:
the Dutch acute stroke trial (DUST) study protocol. BMCNeurol. 2014; 14: 37. doi: 10.1186/1471-2377-
14-37 PMID: 24568540
25. Ferreira RM, Lev MH, Goldmakher G V, Kamalian S, Schaefer PW, Furie KL, et al. Arterial input func-
tion placement for accurate CT perfusion map construction in acute stroke. AJR Am J Roentgenol.
2010; 194: 1330–6. doi: 10.2214/AJR.09.2845 PMID: 20410422
26. Leiva-Salinas C, Provenzale JM, Wintermark M. Responses to the 10 most frequently asked questions
about perfusion CT. AJR Am J Roentgenol. 2011; 196: 53–60. doi: 10.2214/AJR.10.5705 PMID:
21178046
27. Wintermark M, Flanders AE, Velthuis B, Meuli R, van LeeuwenM, Goldsher D, et al. Perfusion-CT as-
sessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients
suspected of acute hemispheric stroke. Stroke. 2006; 37: 979–85. doi: 10.1161/01.STR.0000209238.
61459.39 PMID: 16514093
28. Schaefer PW, Barak ER, Kamalian S, Gharai LR, Schwamm L, Gonzalez RG, et al. Quantitative as-
sessment of core/penumbra mismatch in acute stroke: CT and MR perfusion imaging are strongly cor-
related when sufficient brain volume is imaged. Stroke. 2008; 39: 2986–92. doi: 10.1161/
STROKEAHA.107.513358 PMID: 18723425
29. Campbell BC V, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, et al. Comparison of
computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in is-
chemic stroke. Stroke. 2012; 43: 2648–53. doi: 10.1161/STROKEAHA.112.660548 PMID: 22858726
30. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. A Trial of Imaging Selection and
Endovascular Treatment for Ischemic Stroke. N Engl J Med. 2013; 130208090018002. doi: 10.1056/
NEJMoa1212793
31. Schaefer PW, Mui K, Kamalian S, Nogueira RG, Gonzalez RG, Lev MH. Avoiding “pseudo-reversibility”
of CT-CBV infarct core lesions in acute stroke patients after thrombolytic therapy: the need for algorith-
mically “delay-corrected” CT perfusion map postprocessing software. Stroke. 2009; 40: 2875–8. doi:
10.1161/STROKEAHA.109.547679 PMID: 19520995
32. d’Esterre CD, Aviv RI, Lee TY. The evolution of the cerebral blood volume abnormality in patients with
ischemic stroke: a CT perfusion study. Acta Radiol. 2012; 53: 461–7. doi: 10.1258/ar.2012.110582
PMID: 22434930
33. Hu C, Wu Q, Hu X, Fang X, Zhang T, Ding Y. Hemodynamic studies on brain CT perfusion imaging with
varied injection rates B. 2007; 31: 151–154. doi: 10.1016/j.clinimag.2007.01.008 PMID: 17449374
34. Fieselmann A, Kowarschik M, Ganguly A, Hornegger J, Fahrig R. Deconvolution-Based CT and MR
Brain Perfusion Measurement: Theoretical Model Revisited and Practical Implementation Details. Int J
Biomed Imaging. 2011; 2011: 467563. doi: 10.1155/2011/467563 PMID: 21904538
35. Kudo K, Sasaki M, Yamada K, Momoshima S, Utsunomiya H, Shirato H, et al. Differences in CT perfu-
sion maps generated by different commercial software: quantitative analysis by using identical source
data of acute stroke patients. Radiology. 2010; 254: 200–9. doi: 10.1148/radiol.254082000 PMID:
20032153
36. Marquering H, Nederkoorn PJ, Beenen LF, Lycklama àNijeholt GJ, van den Berg R, Roos YB, et al.
Carotid pseudo-occlusion on CTA in patients with acute ischemic stroke: a concerning observation.
Clin Neurol Neurosurg. Elsevier B.V.; 2013; 115: 1591–4. doi: 10.1016/j.clineuro.2013.02.008 PMID:
23453709
37. Kim JJ, Dillon WP, Glastonbury CM, Provenzale JM, Wintermark M. Sixty-four-section multidetector CT
angiography of carotid arteries: a systematic analysis of image quality and artifacts. AJNR Am J Neuror-
adiol. 2010; 31: 91–9. doi: 10.3174/ajnr.A1768 PMID: 19729539
Effect of CTP Acquisition Time on Ischemic Core Estimation
PLOS ONE | DOI:10.1371/journal.pone.0119409 March 19, 2015 17 / 18
38. Klotz E, König M. Perfusion measurements of the brain: using dynamic CT for the quantitative assess-
ment of cerebral ischemia in acute stroke. Eur J Radiol. 1999; 30: 170–84. PMID: 10452715
39. Smit EJ, Vonken E-J, van Seeters T, Dankbaar JW, van der Schaaf IC, Kappelle LJ, et al. Timing-invari-
ant imaging of collateral vessels in acute ischemic stroke. Stroke. 2013; 44: 2194–9. doi: 10.1161/
STROKEAHA.111.000675 PMID: 23760216
40. Forkert ND, Kaesemann P, Treszl A, Siemonsen S, Cheng B, Handels H, et al. Comparison of 10 TTP
and Tmax estimation techniques for MR perfusion-diffusion mismatch quantification in acute stroke.
AJNR Am J Neuroradiol. 2013; 34: 1697–703. doi: 10.3174/ajnr.A3460 PMID: 23538410
41. Waaijer A, van LeeuwenM. Changes in Cerebral Perfusion after Revascularization of Symptomatic Ca-
rotid Artery Stenosis: CT Measurement. 2007; 245: 541–548. PMID: 17848682
42. Abels B, Klotz E, Tomandl BF, Villablanca JP, Kloska SP, Lell MM. CT perfusion in acute ischemic
stroke: a comparison of 2-second and 1-second temporal resolution. AJNR Am J Neuroradiol. 2011;
32: 1632–9. doi: 10.3174/ajnr.A2576 PMID: 21816919
43. Rosso C, Hevia-Montiel N, Deltour S, Bardinet E, Dormont D, Crozier S, et al. Prediction of infarct
growth based on apparent diffusion coefficients: penumbral assessment without intravenous contrast
material. Radiology. 2009; 250: 184–92. doi: 10.1148/radiol.2493080107 PMID: 19017923
44. Finitsis S, Kemmling A, Havemeister S, Thomalla G, Fiehler J, Brekenfeld C. Stability of ischemic core
volume during the initial hours of acute large vessel ischemic stroke in a subgroup of mechanically
revascularized patients. Neuroradiology. 2014;d. doi: 10.1007/s00234-014-1329-z
45. Fahmi F, Beenen LFM, Streekstra GJ, Janssen NY, de Jong H, Riordan A, et al. Head movement dur-
ing CT brain perfusion acquisition of patients with suspected acute ischemic stroke. Eur J Radiol. Else-
vier Ireland Ltd; 2013; doi: 10.1016/j.ejrad.2013.08.039
46. Yoo AJ, Leslie-Mazwi TM, Jovin TG. Future directions in IAT: better studies, better selection, better tim-
ing and better techniques. J Neurointerv Surg. 2013; 5 Suppl 1: i1–6. doi: 10.1136/neurintsurg-2013-
010741 PMID: 23572460
Effect of CTP Acquisition Time on Ischemic Core Estimation
PLOS ONE | DOI:10.1371/journal.pone.0119409 March 19, 2015 18 / 18
